戻る Agenda
Session 2 : Advancing Pharmacovigilance: regulatory use of database and Risk Management Plan
Session Chair(s)
MinJung Lim, MPharm
Managing director
MediSafe, Pharmacovigilance Services, Korea, Republic of
In-sook Park
Director General
Korean Regulatory Science Center, Korea, Republic of
Speaker(s)
Session 2 - 1
Takashi Waki, PhD, RPh
Pharmaceuticals and Medical Devices Agency, Japan
Epidemiologist
Session 2 - 2
Bonggi Kim
Korea Institute of Drug Safety and Risk Management, Korea, Republic of
Director
Session 2 - 3
Jingyu (Julia) Luan, PhD
AstraZeneca, United States
Executive Regulatory Science Director, BioPharmaceuticals R&D
Juyoung Shin, PharmD, MPH
College of Pharmacy, Sungkyunkwan University, Korea, Republic of
Professor
Hyung-Jin Jung
Janssen Korea, Korea, Republic of
Country Medical Director
Younglim Kim, PhD
National Institute of Food & Drug Safety (NIFDS), Korea, Republic of
Director General
Nam-Kyong Choi, PhD
Seoul National University College of Medicine/Seoul National University Hospital, Korea, Republic of
Research Professor, Division of Clinical Epidemiology